Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors — Stella

Home/Vulvar Adenocarcinoma/AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

View on ClinicalTrials.gov

Recruiting

Back to Vulvar Adenocarcinoma trials

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

NEXT Oncology, Irving, Texas

NEXT Oncology Virginia, Fairfax, Virginia

Key details

Phase

Early testing

Sponsor

Avacta Life Sciences Ltd

Enrollment target

~144 participants

Started

March 2026

Primary completion

January 2029

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.